Use of Inflammatory Markers to Guide Cancer Treatment
- 20 July 2011
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 90 (3), 475-478
- https://doi.org/10.1038/clpt.2011.122
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Preoperative Neutrophil‐to‐Lymphocyte Ratio (NLR) is Associated with Reduced Disease‐free Survival Following Curative Resection of Pancreatic AdenocarcinomaWorld Journal of Surgery, 2011
- Neutrophil-Lymphocyte Ratio Predicts Medium-Term Survival Following Elective Major Vascular Surgery: A Cross-Sectional StudyVascular and Endovascular Surgery, 2011
- Utility of the Neutrophil to Lymphocyte Ratio in Predicting Long-Term Outcomes in Acute Decompensated Heart FailureThe American Journal of Cardiology, 2011
- Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionThe American Journal of Cardiology, 2011
- High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic TherapyClinical Cancer Research, 2010
- Predicting survival for diffuse large B‐cell lymphoma patients using baseline neutrophil/lymphocyte ratioAmerican Journal of Hematology, 2010
- Evaluations of interferon‐γ/interleukin‐4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patientsJournal of Surgical Oncology, 2010
- Inflammation and Cancer: Causes and ConsequencesClinical Pharmacology & Therapeutics, 2010
- Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term FoeClinical Cancer Research, 2009
- Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and CancerDrug Metabolism and Disposition, 2008